A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age

NCT03285997 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza Vaccine

Interventions

BIOLOGICAL: GC3110A
BIOLOGICAL: GCFLU Pre-filled syringe inj.

Sponsor

Green Cross Corporation